Home - Products - Others - Other Targets - 5-Bromo-4-chloro-3-indoxyl-beta-D-cellobioside

5-Bromo-4-chloro-3-indoxyl-beta-D-cellobioside

CAS No. 177966-52-8

5-Bromo-4-chloro-3-indoxyl-beta-D-cellobioside( —— )

Catalog No. M35305 CAS No. 177966-52-8

5-Bromo-4-chloro-3-indoxyl-beta-D-cellobioside is a chromogenic compound used to detect cellobiohydrolases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 29 Get Quote
10MG 43 Get Quote
25MG 71 Get Quote
50MG 106 Get Quote
100MG 155 Get Quote
200MG 233 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    5-Bromo-4-chloro-3-indoxyl-beta-D-cellobioside
  • Note
    Research use only, not for human use.
  • Brief Description
    5-Bromo-4-chloro-3-indoxyl-beta-D-cellobioside is a chromogenic compound used to detect cellobiohydrolases.
  • Description
    5-Bromo-4-chloro-3-indolyl β-D-cellobioside is a chromogenic compound used to detect cellobiohydrolases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    177966-52-8
  • Formula Weight
    570.77
  • Molecular Formula
    C20H25BrClNO11
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C=1C=2C(NC1)=CC=C(Br)C2Cl)[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cortes-Tolalpa L, et al. Halotolerant microbial consortia able to degrade highly recalcitrant plant biomass substrate. Appl Microbiol Biotechnol. 2018 Mar;102(6):2913-2927.?
molnova catalog
related products
  • Chebulic acid

    Chebulic acid, a phenolcarboxylic acid compound isolated from Terminalia chebula, has potent anti-oxidant activity, which breaks the cross-links of proteins induced by advanced glycation end-products (AGEs) and inhibits the formation of AGEs.

  • Koumine

    Koumine has antineoplastic effect, may be a future breast cancer chemotherapeutic agent.

  • SARS-CoV-2 Mpro-IN-9

    SARS-CoV-2 Mpro-IN-9 (compound c7), a nonpeptidic, noncovalent inhibitor of SARS-CoV-2 main protease (Mpro), exhibits potent inhibitory action (IC50 = 0.085 μM) and improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties.